Australia markets closed

Aditxt, Inc. (ADTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2900+0.0189 (+6.97%)
At close: 04:00PM EDT
0.2779 -0.01 (-4.17%)
After hours: 06:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.2711
Open0.2600
Bid0.2779 x 1100
Ask0.2950 x 3000
Day's range0.2600 - 0.2958
52-week range0.2410 - 3.9500
Volume220,911
Avg. volume603,112
Market cap12.97M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.7200
Earnings date13 Nov 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.00
  • Business Wire

    Aditxt, Inc. Partners with Guthy-Renker Affiliate GRS to Launch Consumer Awareness Campaign for AditxtScore™ to Accelerate Adoption and Revenue Growth

    RICHMOND, Va., April 14, 2022--Aditxt, Inc. ("Aditxt", or the "Company") (Nasdaq: ADTX), a biotech innovation company developing technologies focused on mapping and reprogramming the immune system, today is announcing a multiyear partnership with GRS, an affiliate of marketing powerhouse Guthy-Renker, LLC ("Guthy-Renker"). This partnership will focus on building awareness and visibility among consumers and healthcare providers for the AditxtScore™ Immune Monitoring Platform. Aditxt plans to work

  • Business Wire

    Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th

    RICHMOND, Va., April 05, 2022--Aditxt, Inc. ("Aditxt", or the "Company") (Nasdaq: ADTX) has entered into a revenue-sharing agreement with Cellvera, and certain of its affiliates. The agreement is designed to drive strategic revenue and growth starting in 2022 and provide enhanced security for the Company’s $14.5 million loan, plus interest to Cellvera Global Holdings LLC ("Cellvera"), formerly AiPharma Global Holdings LLC. The Company has signed the agreement as consideration for Aditxt’s separa

  • Business Wire

    Aditxt to Participate in the 2022 Virtual Growth Conference

    RICHMOND, Va., March 23, 2022--Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company developing technologies focused on mapping and reprogramming the immune system, announced today that Company CEO & Co-Founder, Amro Albanna, has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT.